MALIGNANCY
Clinical trials for MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new MALIGNANCY trials appear
Sign up with your email to follow new studies for MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental Virus-Targeting drugs tested for deadly rare disorder
Disease control OngoingThis study aims to understand and treat a rare, often fatal disorder called KSHV-associated multicentric Castleman's disease, which is caused by a virus and linked to certain cancers. Researchers are testing several experimental drug combinations in 75 adult participants to see i…
Matched conditions: MALIGNANCY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Pneumonia vaccine tested to shield cancer patients after powerful cell therapy
Prevention TerminatedThis study aimed to see if regular clinic visits and a pneumonia vaccine could help prevent infections in cancer patients after they received CAR-T cell therapy. The plan was to enroll 50 adults with blood cancers or solid tumors who were getting this specialized treatment. Resea…
Matched conditions: MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Prevention
Last updated Mar 18, 2026 14:40 UTC
-
New support program aims to ease cancer journey for black patients
Symptom relief ENROLLING_BY_INVITATIONThis study is testing whether adding a community health worker to standard care improves quality of life for African American patients with advanced cancer. Researchers will compare outcomes between patients receiving standard care alone and those who also get support from a trai…
Matched conditions: MALIGNANCY
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Scientists probe why cancer drugs turn the body against itself
Knowledge-focused OngoingThis study aims to build a database to help researchers understand the autoimmune-like side effects that can occur from powerful cancer immunotherapy drugs. It will collect health data and samples from 32 adult cancer patients receiving these treatments. The goal is to learn who …
Matched conditions: MALIGNANCY
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Withdrawn study sought to see inside tumors before treatment
Knowledge-focused TerminatedThis pilot study aimed to test a new imaging method to see if it could help predict how well patients with solid tumors respond to antibody-based therapies. Participants would have received a special imaging tracer and a PET/CT scan before starting their standard treatment. The g…
Matched conditions: MALIGNANCY
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC